Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Study Identifier
192024-031
CT.gov Identifier
NCT00300443
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Ocular Hypertension
    • Study Drug
  • bimatoprost
    • Phase
    Phase 2/Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinical diagnosis of glaucoma or ocular hypertension in both eyes * Patient requires IOP-lowering drug in both eyes
    Exclusion Criteria:
    * Uncontrolled medical conditions * Ocular seasonal allergies within the past 2 years

    Protocol Summary

    The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable